The reinstatement by the European Patent Office of the patent for the once-weekly Fosamax treatment, the most popular dosing form, could trigger lawsuits by Merck against numerous generic companies selling the product. 欧洲专利局(europeanpatentoffice)恢复福善美专利,可能引发默克针对出售这种药品的众多非专利药制造商提起诉讼。
Objective: To study the effect of preventing bone loss of Fosamax in aged males. 目的:研究阿伦膦酸钠制剂福善美防治老年男性骨质丢失的作用。